Other
Acanthosis Nigricans
5
Pipeline Programs↗
0
Active Trials↗
5
Companies Involved↗
Acanthosis Nigricans is an early-stage landscape with 5 programs across 5 companies. The most active players are Pfizer, Eastern Cooperative Oncology Group, Aucta Pharmaceuticals, Inc. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 3
No programs
Analysis
Trial Status
7
clinical trials
Completed6 · 86%
Unknown status1 · 14%
Clinical Trials
Trial Activity
7 trials
Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity
Unknown status·—·Phase 4·NCT02438020·30 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)